In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s decision to deny an emergency appeal to block enforcement of a controversial Texas abortion law (00:35), a recent report on Medicare hospital fund insolvency (03:25), and an FDA committee meeting on complex gene therapy safety questions (11:11). …
Opportunities for Patient Centricity in Life Sciences
September 2, 2021
Patient centricity is no longer a buzzword, it’s redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and …
Importance of Culture in Return to Workplace Planning
August 5, 2021
Climbing COVID-19 vaccination rates have enabled many countries to relax social distancing requirements and business leaders to implement their return to workplace plans. In this episode, Ryan and Jen are joined by Vynamic’s Lauren Scandone and Stefanie Christmas to discuss the importance of culture in developing and executing those plans. The past eighteen months have …
COVID-19 Business Response – Phase 4: The Great Culture Reset
The COVID-19 vaccine roll-out is well underway, and with full re-openings and talk of “return to normal”, many business leaders are finalizing or implementing return to workplace plans. While many organizations may have already put significant thought into safely re-opening physical workplaces, there are additional complexities that should be considered that could have far greater …
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Biden administration’s interim final rule banning surprise billing (00:35), Walmart’s launch of a private band insulin analog (04:21), and interim trial results for in vivo CRISPR-based genome editing candidate NTLA-2001 (07:00). Podcast Tags: surprise billing, health insurance, diabetes, drug prices, …
Advancement in technologies and scientific platforms have enabled personalized approaches that acknowledge the future of healthcare shouldn’t be “one-size-fits-all”. Jen, Mindy, and Ryan discuss the drivers behind this innovation, and the impact on both the practice and development of therapeutics. The episode opens with a discussion of what’s sparking this demand for personalization (00:45) and …
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s ruling to uphold the Affordable Care Act (ACA) (00:35), the announcement of additional mandatory payment models from the Center for Medicare & Medicaid Innovation (CMMI) (04:20), America’s Health Insurance Plans rebranding as “AHIP” (08:13), the Institute of Clinical …
During a crisis, we have no choice but to show resilience and solve problems quickly. How did our healthcare systems manage to continue to save lives under unfamiliar and stressful conditions throughout the COVID-19 Pandemic? In Vynamic’s latest Insight, we focus on how healthcare organizations adapted, collaborated, and iteratively experimented to breathe life into innovation.
Six years after the Medicare Access and CHIP Reauthorization Act (MACRA 2015), Vynamic’s Mindy, Ryan, and Jen discuss where we are today in the transition from Fee-For-Service (FFS) reimbursement to Value-Based Care (VBC). The episode opens with an acknowledgment that VBC is at a crossroads – the transition has been bumpy, VBC models have been …
